未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏RETRACTED: Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine™) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial (Retracted Article)撤回: 基于重组受体结合结构域的蛋白质亚单位疫苗的安全性和免疫原性 (Noora疫苗™) 针对成人的新型冠状病毒肺炎: 一项随机,双盲,安慰剂对照的1期试验 (撤回的文章)
Salimian, Jafar; Ahmadi, Ali; Amani, Jafar; Olad, Gholamreza; Halabian, Raheleh; Saffaei, Ali; Arabfard, Masoud; Nasiri, Mojtaba; Nazarian, Shahram; Abolghasemi, Hassan; Alishiri, Gholamhossein
分享
收藏Preclinical study of formulated recombinant nucleocapsid protein, the receptor binding domain of the spike protein, and truncated spike (S1) protein as vaccine candidates against COVID-19 in animal models
Nazarian, Shahram; Olad, Gholamreza; Abdolhamidi, Raziyeh; Motamedi, Mohammad Javad; Kazemi, Rouhollah; Kordbacheh, Emad; Felagari, Alireza; Olad, Hanieh; Ahmadi, Ali; Bahiraee, Alireza; Farahani, Parisa; Haghighi, Leila; Hassani, Faezeh; Hajhassan, Vahideh; Nadi, Mona; Sheikhi, Abdolkarim; Salimian, Jafar; Amani, Jafar
分享
收藏
分享
收藏
分享
收藏
分享
收藏